IPOs for July 16th
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
IPO for Chinese Wealth Manager Jupai Holdings (JP) Trades Modestly Higher
July 16, 2015 2:13 PM EDTToday's IPO for Chinese wealth management firm Jupai Holdings (NYSE: JP) is trading at $10.76 after pricing 5,300,000 American Depositary Shares (ADSs), each representing six ordinary shares of the Company, at $10.00 per ADS. The ADSs opened earlier on the NYSE at $10.41.
The IPO... More
ProNAi Therapeutics (DNAI) IPO Opens Up 69%
July 16, 2015 11:00 AM EDTToday's IPO for ProNAi Therapeutics, Inc. (Nasdaq: DNAI) opened for trading at $28.68 after pricing of its initial public offering of 8,100,000 shares of its common stock at a price to the public of $17.00 per share
Jefferies LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering. BofA Merrill Lynch is also serving as ProNAi's Strategic IPO Advisor. Wedbush PacGrow and SunTrust Robinson Humphrey are acting as co-managers.
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of... More
ProNAi Therapeutics (DNAI) Prices 8.1M Common Stock IPO at $17/Share
July 16, 2015 10:13 AM EDTProNAi Therapeutics, Inc. (Nasdaq: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced the pricing of its initial public offering of 8,100,000 shares of its common stock at a price to the public of... More
Jupai Holdings (JP) Prices 5.3M ADS IPO at $10/ADS, at the Lower-End of Expectations
July 16, 2015 10:12 AM EDTJupai Holdings Limited ("Jupai" or the "Company") (NYSE: JP), a leading third-party wealth management service provider in China, today announced that its initial public offering of 5,300,000 American Depositary Shares ("ADSs"), each representing six ordinary shares of the Company, was priced at $10.00 per... More

